Navigating the Impending Merger: Comprehensive Insights into the Combined R&D Tax Relief Schemes
The recent Autumn Statement officially announced the merger of the R&D tax relief schemes, scheduled to take effect from 1st April 2024, for accounting periods starting after this date. This significant reform, following a consultation opened in January 2023 and subsequent policy papers, particularly impacts companies engaged in Research and Development (R&D) activities.
The supporting documentation, released shortly after the Autumn Statement, outlines the groundwork for combining the Small and Medium Enterprise (SME) and Research and Development Expenditure Credit (RDEC) schemes. This impending merger, affecting all claiming companies, prompted our comprehensive analysis of the associated rules.
Confirmed in the Autumn Statement on 22nd November, the merger will follow RDEC rules, highlighting the role of R&D in a company’s pre-tax income. Larger businesses accustomed to the RDEC scheme’s ‘above-the-line credit’ approach may experience a smoother transition, while SMEs are advised to proactively plan for the impending changes.
Key Components of the Merged Scheme:
1. Definition of R&D: The fundamental DSIT Guidelines, remains unaltered, requiring companies to demonstrate uncertainties and advancements in science or technology.
2. Rates of Relief: A proposed unified relief rate of 20%, resulting in a net benefit of 15% or 16.2% depending on corporation tax rate for companies Large and Small.
3. A specialised relief rate scheme for SME R&D-intensive companies (net benefit of 27%) will persist alongside the merged scheme. Though after March 2024 the definition of a research-intensive company will drop from R&D spend at 40% to 30%, adding an anticipated 5,000 eligible companies to this scheme.
4. SME PAYE Loss Cap Rules: The more favourable SME scheme PAYE loss cap rules are slated for adoption, with the notional tax rate applied to loss-making companies set at 19%.
5. Subcontracted R&D: The scheme permits broader claims on outsourced R&D costs for the R&D decision maker, akin to the current SME scheme, though details on contract terms that specify this are still being consulted on.
6. Subsidised R&D: Unlike the current SME scheme, subsidised expenditure rules won’t apply to the new merged scheme, ensuring that relief remains unaffected if a company receives a grant for R&D costs.
In the earlier spring statement and previous announcements, the Government had already added in maths and cloud–computing costs as eligible and that overseas sub-contractor costs would become ineligible unless the R&D has to take place abroad for geographical, social or legal reasons.
Impact on Businesses:
The merger has broad implications for companies involved in R&D activities, potentially reducing benefits for smaller enterprises. Noteworthy changes to rules on R&D decision makers, subsidised R&D and overseas costs necessitate careful planning, especially for businesses receiving grants or contracts for sub-contracted R&D. The increased benefit rate for the RDEC scheme to 15-16% is a significant boost for Large Companies but will this be competitive enough among international schemes where some countries offer the following benefit:
United States 22%
For the SME in the UK the benefit has dropped from 25-33% to 15-27%, a significant hit and again does this make the UK an attractive place to carry out R&D, especially when HMRC are being quite aggressive in challenging R&D claims made by SMEs.
How to prepare:
Contrary to expectations of a potential one-year delay, the Autumn Statement confirmed the merger’s timely implementation. Businesses, especially SMEs, are urged to be proactive in readiness for potential changes. We welcome inquiries for advice, offering assistance in evaluating impacts, resource sourcing, contract terms and recommending necessary organisational adjustments.
The government’s objective is to make the UK a world leader in R&D as a driver of innovation and economic growth. The merged scheme aligns with their goal of tax simplification and prudent use of taxpayers’ money.
Graph source – New data on R&D Tax Incentives from OECD
Article written by: Ian Davie, Senior Consultant – TBAT Innovation Ltd
To discuss how we may be able to assist with your R&D Tax Claim, or if you have any queries, please contact Jo Rudzki, confirming you are an STC Member email@example.com or visit www.tbat.co.uk for further information
Author: TBAT Innovation
Date: 16 February 2024TBAT Innovation is excited to announce the launch of The Innovation Challenge, an initiative aimed at supporting SMEs in their quest for innovation and growth. The programme, meticulously crafted by TBAT’s expert team, brings together key partners to provide invaluable support and guidance to businesses looking to innovate. The Innovation Challenge, powered by TBAT, with … Continued
Author: TBAT Innovation
Date: 25 January 2024About TBAT Innovation TBAT are a value-led independent consultancy with over 20 years’ experience working with technology & research and development organisations all over the UK – helping them to progress their projects from beginning to end. We believe that offering our wide range of innovation support services is crucial to helping companies succeed with … Continued
Author: TBAT Innovation
Date: 25 January 2024Though there are varied ways of receiving funding for small and large businesses, grant funding is a very lucrative way to gain the money you need without having to repay it. Grants can frequently be the difference between speeding up the release of a new project with a competitive edge and having to sit on … Continued